WHO ICTRP trial

a Random, Double-blind, Double-simulation, Multicenter study of Chinese Herbal…

ITMCTR2200005688 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting

Key facts

Trial ID ITMCTR2200005688
Public title a Random, Double-blind, Double-simulation, Multicenter study of Chinese Herbal Compound Jinji Granules (CJG) for treatment Primary Premature Ejaculation: (Gan depression an Shen deficiency syndrome)
Scientific title a Random, Double-blind, Double-simulation, Multicenter study of Chinese Herbal Compound Jinji Granules (CJG) for treatment Primary Premature Ejaculation: (Gan depression an Shen deficiency syndrome)
Primary sponsor Xiyuan Hospital of China Academy of Chinese Medical Sciences
Registry International Traditional Medicine Clinical Trial Registry (ITMCTR)
Recruitment status Recruiting
Study type Interventional study
Countries China
Conditions Premature ejaculation
Interventions Experimental group:Compound Jinji Granules(CJG)+Dapoxetine simulator.CGJ is taken twice a day, one bag at a time, half an hour after breakfast and dinner, and after brewing with warm water. Dapoxetine simulator,30mg each time, 3 hours…
Registration date Mar 9, 2022
Target size Experimental group:46;Control group:46
Secondary IDs ChiCTR2200057359;ChiMCTR2200005688
Registry page itmctr.ccebtcm.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations